title: Administration of CDDP via the superior mesenteric artery for peritoneal carcinomatosis due to gastric cancer.
authors.forename: H
authors.initials: H
authors.lastname: Taniguchi
authors.forename: T
authors.initials: T
authors.lastname: Daidoh
authors.forename: A
authors.initials: A
authors.lastname: Itoh
authors.forename: H
authors.initials: H
authors.lastname: Horie
authors.forename: T
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: K
authors.initials: K
authors.lastname: Sawai
authors.forename: O
authors.initials: O
authors.lastname: Kojima
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: A
authors.initials: A
authors.lastname: Hagiwara
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000188:drug therapy / Q000556:secondary*; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008638:Mesenteric Arteries; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D010534:Peritoneal Neoplasms / Q000188:drug therapy / Q000556:secondary*; D013274:Stomach Neoplasms / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C055423:didimethylsulfoxide dichloroplatinum(II)